Alan John Michelich,Thomas Dedenroth Miller,Oleksandr Shvets,Anuar Imanbayev,Brad Warren Van Orden
申请号：
US16417032
公开号：
US20190388512A1
申请日:
2019.05.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to a novel administration regime useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the device further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.
